Johnson & Johnson and partner Sanofi will stop a late-stage trial of an experimental vaccine to prevent infections caused by ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best stocks to buy for financial stability. Investing in stocks is one of the most effective ...

Pharmaceutical giant Johnson & Johnson (JNJ) is planning to sell its stroke care business called “Cerenovus” for $1 billion or more. Leverage the power of TipRanks' Smart Score, a data-driven ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best medical device stocks to buy right now. According to a report by Mordor Intelligence ...

J&J is exploring the sale of Cerenovus, a stroke care business, in a deal potentially worth $1 billion to $1.5 billion. The company spent over $30 billion on medtech acquisitions in the past three ...

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Speaker Mike Johnson said Sunday that tentative plans for a House Budget Committee markup this week may now be postponed as Republican lawmakers continue to struggle to reach an agreement on the ...

It was inevitable that Donald Trump’s radical and legally dubious ambitions would spark extensive litigation. What’s more, the president and his White House team shouldn’t be at all ...